本公司产品仅供体外研究使用,不用于临床诊断

CAB39 Polyclonal Antibody

规格: / 20μL / 60μL / 120μL / 200μL
价格: / ¥420 / ¥1010 / ¥1640 / ¥2365

货号:E-AB-13421

宿主: Rabbit

反应性: H,M

应用: WB,IHC

  • 详情
  • Overview

    Synonyms Cab39,CAB39,Calcium binding protein 39,Calcium-binding protein 39,CGI 66,CGI-66,CGI66,MO25 alpha,MO25,Mouse protein 25 alpha,Protein Mo25,CAB39抗体
    Swissprot Q9Y376
    Source Rabbit
    Reactivity Human,Mouse
    Immunogen Synthetic peptide of human CAB39
    Application WB(Detection kit: E-IR-R304),IHC(Detection kit: E-IR-R213)
    Recommended dilution WB,,1:500-1:2000;IHC,,1:50-1:200;
    Concentration 1.7 mg/mL
    Clonality Polyclonal

    Properties

    Cellular localization Cytoplasm.
    Isotype IgG
    Purification Affinity purification
    Conjugation Unconjugated
    Storage instructions Store at -20℃. Avoid freeze / thaw cycles.
    Storage buffer PBS with 0.05% sodium azide, 50% glycerol, PH7.3
    Background Peutz-Jeghers Syndrome (PJS) is a rare hereditary disease characterized by melanocytic macules of the lips, gastrointestinal hamartomatous polyps and an increased risk for many classes of cancer. The serine/threonine kinase LKB1 (also designated STK11) has been identified as the gene mutated in PJS. LKB1 activity increases upon the binding of a regulatory complex consisting of the STE20-related adaptor-alpha (STRAD alpha) pseudo kinase and the calcium binding protein 39 (MO25 alpha). STRAD and MO25 determine the subcellular localization of LKB1 by initiating its translocation from the nucleus to the cytoplasm, thus regulating the tumor suppressor activity of LKB1. The LKB1/STRAD/MO25 complex acts as an AMP-activated protein kinase kinase (AMPKK).
    如有任何问题,请拨打电话 027-87879180 或填写 在线留言 我们会第一时间联系您。
    ×
    var _hmt = _hmt || []; MIP.watch('count', function () { console.log("sdsfs"); _hmt.push(['_trackEvent', 'consult_mip', 'click', 'detail page']); })